Artificial Intelligence and Bioinformatics for Disease Diagnosis and Prognostic Assessment

Dear Colleagues,

Artificial intelligence (AI) and bioinformatics are revolutionizing the field of disease diagnosis and prognostic assessment by providing innovative tools for analyzing complex biological data, and the integration of these technologies has greatly enhanced the precision, speed, and accuracy of diagnosing diseases, while also offering more personalized and predictive models for patient outcomes. In a world where healthcare systems are increasingly burdened by vast amounts of biological data, the application of AI and bioinformatics offers promising solutions to improve clinical decision-making and patient care.

AI techniques, particularly machine learning (ML) and deep learning (DL), are being employed to analyze large datasets, including genomic sequences, proteomic profiles, and clinical data. By identifying hidden patterns and relationships within these datasets, AI can assist in the early detection of diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders. Moreover, AI algorithms can be trained to predict disease progression, response to treatment, and potential complications, thus aiding clinicians in making informed decisions tailored to individual patients.

Bioinformatics, on the other hand, plays a vital role in processing, analyzing, and interpreting biological data, particularly in genomics and systems biology. It involves the development of computational tools and algorithms that allow researchers to understand the underlying mechanisms of diseases at a molecular level. By integrating genomic, transcriptomic, and proteomic data, bioinformatics enables the identification of biomarkers and molecular signatures that can be used for both diagnostic and prognostic purposes. This interdisciplinary approach has led to the development of precision medicine, where treatments are tailored based on the genetic makeup of the patient and the disease.

The synergy between AI and bioinformatics is particularly evident in the development of predictive models for disease prognosis. AI-driven bioinformatics tools are now capable of analyzing vast amounts of omics data to predict disease outcomes and suggest personalized treatment strategies. For instance, AI algorithms trained on genomic data can predict the likelihood of disease recurrence in cancer patients or identify high-risk individuals for chronic conditions such as diabetes and heart disease. Additionally, AI models can continuously update their predictions as new data becomes available, allowing for real-time prognostic assessment and dynamic treatment planning.

The application of AI and bioinformatics in disease diagnosis and prognosis is not limited to a single disease or patient group but spans a wide range of medical conditions. From early cancer detection and personalized cancer therapies to predicting patient outcomes in infectious diseases, these technologies are paving the way for more effective healthcare practices. As the field evolves, the integration of AI with bioinformatics will likely lead to more accurate, efficient, and accessible diagnostic and prognostic tools, driving forward the vision of personalized, data-driven medicine.

This Special Issue is focused on the transformative role of AI and bioinformatics in disease diagnosis and prognostic assessment. It invites researchers and experts to contribute their cutting-edge research, innovations, and findings that can further advance the applications of AI and bioinformatics in medical science. We encourage submissions that explore new methodologies, case studies, and breakthroughs in this exciting and rapidly developing field, aiming to push the boundaries of personalized medicine and improve patient care worldwide.

Dr. Ana María Torres Aranda
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• artificial intelligence
• bioinformatics
• machine learning
• deep learning
• big data analysis
• genomic sequences
• proteomic profiles
• clinical data
• disease diagnosis
• prognostic assessment